5359

543328

KRSNAA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

KRSNAA DIAGNOSTICS LTD Share Price Today

KRSNAA DIAGNOSTICS LTD is currently trading at ₹533, down by ₹0.25 from the previous close. The stock touched an intraday high of ₹540.00 and a low of ₹532.00 during the latest trading session. Over the past one year, KRSNAA DIAGNOSTICS LTD has delivered a loss of 20.57%, while the stock has declined 5.59% in the last one month.

KRSNAA DIAGNOSTICS LTD performance

Today’s low Today’s high
₹ 532.00 ₹ 540.00
₹ 533.65
52 week low 52 week high
₹ 515.00 ₹ 894.40
₹ 533.65
Open Price ₹ 536.05
Prev. Close ₹ 533.25
Volume (Shares) 72963.00
Total traded value ₹ 389.36
Upper Circuit ₹ 639.90
Lower Circuit ₹ 426.60
info

Investment Returns

Over 1 Month -5.59% Over 3 Months -10.72% Over 6 Months -25.94% Over 1 Year -20.57%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

KRSNAA DIAGNOSTICS LTD fundamentals


  • Market cap (Cr) 1,731.10
  • P/E Ratio (TTM) 16.91
  • Beta 0.92
  • Book Value / share 305.77
  • Return on equity 9.69%
  • EPS (TTM) 31.65
  • Dividend yield 0.37%
  • Net profit/quarter (Cr) 43.38
info icon alternate text
  • Market cap (Cr) 1,732.20
  • P/E Ratio (TTM) 16.91
  • Beta 0.88
  • Book Value / share 305.77
  • Return on equity 9.69%
  • EPS (TTM) 31.65
  • Dividend yield 0.37%
  • Net profit/quarter (Cr) 43.38
info icon alternate text

KRSNAA DIAGNOSTICS LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 173.02
Operating Expense 150.30
Net Profit 43.38
Net Profit Margin (%) 25.07
Earnings Per Share (EPS) 13.37
EBITDA 88.24
Effective Tax Rate (%) 19.85
Particulars DEC 2025 (Values in Cr)
Revenue 159.43
Operating Expense 142.01
Net Profit 16.49
Net Profit Margin (%) 10.34
Earnings Per Share (EPS) 5.08
EBITDA 51.47
Effective Tax Rate (%) 22.29
Particulars SEP 2025 (Values in Cr)
Revenue 182.88
Operating Expense 156.46
Net Profit 23.24
Net Profit Margin (%) 12.70
Earnings Per Share (EPS) 7.12
EBITDA 62.22
Effective Tax Rate (%) 24.12
Particulars JUN 2025 (Values in Cr)
Revenue 175.62
Operating Expense 153.28
Net Profit 19.56
Net Profit Margin (%) 11.13
Earnings Per Share (EPS) 6.10
EBITDA 54.10
Effective Tax Rate (%) 25.74
Particulars MAR 2025 (Values in Cr)
Revenue 174.65
Operating Expense 149.90
Net Profit 21.07
Net Profit Margin (%) 12.06
Earnings Per Share (EPS) 6.52
EBITDA 57.76
Effective Tax Rate (%) 27.90
Particulars MAR 2026 (Values in Cr)
Revenue 690.95
Operating Expense 602.04
Net Profit 102.68
Net Profit Margin (%) 14.86
Earnings Per Share (EPS) 31.69
EBITDA 256.02
Effective Tax Rate (%) 22.40
Particulars MAR 2025 (Values in Cr)
Revenue 681.70
Operating Expense 597.77
Net Profit 82.81
Net Profit Margin (%) 12.14
Earnings Per Share (EPS) 25.65
EBITDA 222.32
Effective Tax Rate (%) 24.44
Particulars MAR 2024 (Values in Cr)
Revenue 590.02
Operating Expense 534.87
Net Profit 58.56
Net Profit Margin (%) 9.92
Earnings Per Share (EPS) 18.45
EBITDA 162.97
Effective Tax Rate (%) 18.59
Particulars MAR 2023 (Values in Cr)
Revenue 464.08
Operating Expense 401.30
Net Profit 63.51
Net Profit Margin (%) 13.68
Earnings Per Share (EPS) 20.23
EBITDA 143.65
Effective Tax Rate (%) 22.72
Particulars MAR 2022 (Values in Cr)
Revenue 454.89
Operating Expense 380.22
Net Profit 70.70
Net Profit Margin (%) 15.54
Earnings Per Share (EPS) 23.66
EBITDA 149.48
Effective Tax Rate (%) 21.09
Particulars MAR 2025 (Values in Cr)
Book Value / Share 273.39
ROE % 9.17
ROCE % 12.12
Total Debt to Total Equity 0.21
EBITDA Margin 29.80
Particulars MAR 2024 (Values in Cr)
Book Value / Share 250.79
ROE % 7.34
ROCE % 9.62
Total Debt to Total Equity 0.12
EBITDA Margin 25.76
Particulars MAR 2023 (Values in Cr)
Book Value / Share 235.28
ROE % 8.73
ROCE % 11.26
Total Debt to Total Equity 0.05
EBITDA Margin 29.09
Particulars MAR 2022 (Values in Cr)
Book Value / Share 217.98
ROE % 9.99
ROCE % 13.90
Total Debt to Total Equity 0.06
EBITDA Margin 32.14
Particulars MAR 2017 (Values in Cr)
Book Value / Share 20.79
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.86
EBITDA Margin 34.35
Particulars MAR 2025 (Values in Cr)
Book Value / Share 274.65
ROE % 9.69
ROCE % 12.69
Total Debt to Total Equity 0.21
EBITDA Margin 32.42
Particulars MAR 2024 (Values in Cr)
Book Value / Share 251.73
ROE % 7.52
ROCE % 9.79
Total Debt to Total Equity 0.12
EBITDA Margin 27.41
Particulars MAR 2023 (Values in Cr)
Book Value / Share 235.63
ROE % 8.89
ROCE % 11.47
Total Debt to Total Equity 0.05
EBITDA Margin 30.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 218.72
ROE % 19.71
ROCE % 16.99
Total Debt to Total Equity 0.30
EBITDA Margin 32.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share -16.20
ROE % -204.02
ROCE % 59.91
Total Debt to Total Equity 13.27
EBITDA Margin 90.51
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 68.43
Total Assets 1281.59
Total Liabilities 1281.59
Total Equity 882.77
Share Outstanding 3
Price to Book Ratio 2.86
Return on Assets (%) 6.05
Return on Capital (%) 7.4
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 175.18
Total Assets 1171.91
Total Liabilities 1171.91
Total Equity 809.80
Share Outstanding 3
Price to Book Ratio 2.44
Return on Assets (%) 4.84
Return on Capital (%) 6.2
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 108.79
Total Assets 909.89
Total Liabilities 909.89
Total Equity 738.73
Share Outstanding 3
Price to Book Ratio 1.95
Return on Assets (%) 6.82
Return on Capital (%) 8.22
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 241.88
Total Assets 876.15
Total Liabilities 876.15
Total Equity 684.40
Share Outstanding 3
Price to Book Ratio 2.22
Return on Assets (%) 7.80
Return on Capital (%) 9.63
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 67.90
Total Assets 1283.31
Total Liabilities 1283.31
Total Equity 893.29
Share Outstanding 3
Price to Book Ratio 2.86
Return on Assets (%) 6.45
Return on Capital (%) 7.82
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 174.66
Total Assets 1171.56
Total Liabilities 1171.56
Total Equity 815.24
Share Outstanding 3
Price to Book Ratio 2.44
Return on Assets (%) 4.99
Return on Capital (%) 6.35
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 108.20
Total Assets 909.38
Total Liabilities 909.38
Total Equity 742.50
Share Outstanding 3
Price to Book Ratio 1.95
Return on Assets (%) 6.98
Return on Capital (%) 8.37
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 241.75
Total Assets 877.05
Total Liabilities 877.05
Total Equity 686.75
Share Outstanding 3
Price to Book Ratio 2.22
Return on Assets (%) 8.06
Return on Capital (%) 9.92
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 152.91
Total Assets 609.27
Total Liabilities 609.27
Total Equity 231.86
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 30.35
Return on Capital (%) 41.38
Particulars MAR 2025 (Values in Cr)
Net Income 102.68
Cash from Operations 107.26
Cash from Investing -99.60
Cash from Financing 13.75
Net change in Cash 1.47
Free Cash Flow 233.89
Particulars MAR 2024 (Values in Cr)
Net Income 70.00
Cash from Operations 43.14
Cash from Investing -128.87
Cash from Financing 84.18
Net change in Cash -20.34
Free Cash Flow 237.03
Particulars MAR 2023 (Values in Cr)
Net Income 80.20
Cash from Operations 89.43
Cash from Investing -108.88
Cash from Financing -33.14
Net change in Cash -65.73
Free Cash Flow 230.79
Particulars MAR 2022 (Values in Cr)
Net Income 86.51
Cash from Operations 135.05
Cash from Investing -240.63
Cash from Financing 175.99
Net change in Cash 63.77
Free Cash Flow 267.27
Particulars MAR 2025 (Values in Cr)
Net Income 109.60
Cash from Operations 109.07
Cash from Investing -101.82
Cash from Financing 13.90
Net change in Cash 1.45
Free Cash Flow 234.76
Particulars MAR 2024 (Values in Cr)
Net Income 71.94
Cash from Operations 43.19
Cash from Investing -128.87
Cash from Financing 84.20
Net change in Cash -20.27
Free Cash Flow 237.08
Particulars MAR 2023 (Values in Cr)
Net Income 82.19
Cash from Operations 88.61
Cash from Investing -108.54
Cash from Financing -33.13
Net change in Cash -66.19
Free Cash Flow 229.97
Particulars MAR 2022 (Values in Cr)
Net Income 89.60
Cash from Operations 135.33
Cash from Investing -241.09
Cash from Financing 176.03
Net change in Cash 63.64
Free Cash Flow 267.60
Particulars MAR 2021 (Values in Cr)
Net Income 295.45
Cash from Operations 126.33
Cash from Investing -67.37
Cash from Financing 20.03
Net change in Cash 71.32
Free Cash Flow 197.37
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8432.15 61.98 12.79 121241.38 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 53.09 24.02 2.89 99.50 40.75 76.00
SHREE PACETRONIX LTD. 138.30 16.50 2.91 51.86 66.10 283.15
TRANSGENE BIOTEK LTD. 2.96 0.00 2.67 22.43 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8432.15 80.76 12.16 121241.38 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 37.42 0.00 -9.10 27.95 30.30 57.48
KOVAI MEDICAL CENTER & HO 5844.00 26.15 4.84 6393.34 5010.00 6725.00

KRSNAA DIAGNOSTICS LTD shareholding pattern

Holding
55.08%
27.11%
3.9%
13.89%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

KRSNAA DIAGNOSTICS LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
533.65 0.07 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 535.60
  • 26 Days 551.60
  • 10 Days 538.50
  • 50 Days 570.20
  • 12 Days 540.00
  • 100 Days 607.80
  • 20 Days 546.70
  • 200 Days 661.10
536.67 PIVOT
First Support 528.33 First Resistance 541.58 Second Support 523.42 Second Resistance 549.92 Third Support 515.08 Third Resistance 554.83
RSI 37.91 ADX 5.99 MACD -11.62 Williams % R -92.97 Commodity Channel Index (CCI) -86.41
Date 2026-06-17 Week 43135.00 Same Day 27662.00 Month 43902.00
1 Year 0.93 3 Year 1.04
Over 1 Month
-5.59% down
Over 1 Year
-20.57% down
Over 3 Months
-10.72% down
Over 3 Years
-2.93% down
Over 6 Months
-25.94% down
Over 5 Years
-11.58% down

KRSNAA DIAGNOSTICS LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
12 Sep 2025 2.75 Final 12 Sep 2025 Equity shares
13 Sep 2024 2.5 Final 13 Sep 2024 Equity shares
15 Sep 2023 2.75 Final 16 Sep 2023 Equity shares
15 Sep 2022 2.5 Final 16 Sep 2022 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
12 Sep 2025 2.75 Final 12 Sep 2025 Equity shares
13 Sep 2024 2.5 Final 13 Sep 2024 Equity shares
15 Sep 2023 2.75 Final 16 Sep 2023 Equity shares
15 Sep 2022 2.5 Final 16 Sep 2022 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Krsnaa Diagnostics Ltd?

Answer Field

Krsnaa Diagnostics Ltd share price is for NSE ₹ 533.00 & for BSE ₹ 534.00 as on Jun 18 2026 03:29 PM.

What is the Market Cap of Krsnaa Diagnostics Ltd Share?

Answer Field

The market cap of Krsnaa Diagnostics Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 18 2026 03:29 PM.

What is the 52 Week High and Low of Krsnaa Diagnostics Ltd?

Answer Field

The 52 Week High and Low of Krsnaa Diagnostics Ltd for NSE is ₹ 894.40 and ₹ 515.00 and for BSE is ₹ 891.80 and ₹ 502.20.

What is 1 year return for Krsnaa Diagnostics Ltd?

Answer Field

The 1 year returns on the stock has been -20.57%.

What is the P/E Ratio of Krsnaa Diagnostics Ltd Share?

Answer Field

As on Jun 18 2026 03:29 PM the price-to-earnings (PE) ratio for Krsnaa Diagnostics Ltd share is 16.91.

What is the PB ratio of Krsnaa Diagnostics Ltd Share?

Answer Field

As on Jun 18 2026 03:29 PM, the price-to-book (PB) ratio for Krsnaa Diagnostics Ltd share is 305.77.

How to Buy Krsnaa Diagnostics Ltd Share?

Answer Field

You can trade in Krsnaa Diagnostics Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Krsnaa Diagnostics Ltd Share on Bajaj Broking App?

Answer Field

To buy Krsnaa Diagnostics Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Krsnaa Diagnostics Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|